抗血管生成疗法在淋巴瘤中的应用
摘要
人体内大多数细胞的生存和发挥作用，都必须从血管中获取氧气和其他营养物质，肿瘤细胞更不例外。研究表明如果没有血液供应提供这些重要物质并带走废物，肿瘤直径不会超过1～2mm。
出处
《医学新知》
CAS
2009年第6期361-364,共4页
New Medicine
基金
国家自然科学基金（编号30840009）
参考文献14
-
1Peters B A, Diaz L A, Polyak K et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature [J]. Nat Med,2005,11: 261-262.
-
2Jorgensen J M,Sorensen F B,Bendix K,et al. Angiogenesis in non-Hodgkin 's lymphoma: clinicopathological correlations and prognostic significance in specific subtypes [ J ]. Leuk Lymphoma,2007,48:584-595.
-
3Witzig T E, Vose J M, Pietronigro D, et al. Preliminary results from a phase II study of lenalidomide oral monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma. 2007 ASCO Annual Meeting Proceedings [ J ]. Clin J Oncol 2007,25 ( Suppl ) :8066.
-
4Ganjoo K N,An C S,Robertson M J,et al. Rituximab,bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis [ J]. Leuk Lymphoma,2006 ,47 :998-1005.
-
5Smith S M,Grinblatt D,Johnson J L,et al. Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas : a phase II trial of the Cancer and Leukemia Group B [ J ]. Br J Haematol, 2008,140: 313-319.
-
6Kaufmann H, Raderer M, Wohrer S et al. Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma [ J ]. Blood, 2004, 104 : 2269 -2271.
-
7Ruan J,Coleman M, Furman R R et al. Targeting angiogenesis in mantle cell lymphoma: clinical efficacy and correlative studies of a phase II trial of RT-PEPC ( rituximab, thalidomide and metronomic oral chemotherapy with prednisone,etoposide,procarbazine and cyclophosphamide) in relapsed/refractory disease [ J ]. Blood, 2006,108 : 2751.
-
8Buckstein R, Kerbel RS, Shaked Y,et al. High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin 's lymphoma [ J ]. Clin Cancer Res ,2006,12:5190-5198.
-
9Witzig T E, Geyer S M, Ghobrial I, et al. Phase II trial of single-agent temsimlimus (CC1-779) for relapsed mantle cell lymphoma [ J ]. Clin J Oncol,2005,23:5347-5356.
-
10Grant S,Easley C, Kirkpatrick P. Vorinostat [ J]. Nat Rev Drug Discov ,2007 , 6 : 21-22.
二级参考文献10
-
1Bennett S A, Tenniswood M, Chen J H, et al. Chronic cerebral hypoperfusion elicits neuronal apoptosis and behavioral impairment. Neuroreport, 1998, 9(1): 161.
-
2Sekhon L H, Morgan M K, Spence I, et al. Chronic cerebral hypoperfusion and impaired neuronal function in rats. Stroke, 1994, 25(5): 1022.
-
3Poser S, Storm D R. Role of Ca2+-stimulated adenylyl cyclases in LTP and memory formation. Int J Dev Neurosci, 2001, 19(4): 387.
-
4Wilson M A, Tonegawa S. Synaptic plasticity, place cells and spatial memory: study with second generation knockouts. Trends Neurosci, 1997, 20(3): 102.
-
5Mori E. Impact of subcortical ischemic lesions on behavior and cognition. Ann N Y Acad Sci, 2002,977(2): 141.
-
6Pantoni L, Garcia J H. Pathogenesis of leukoaraiosis:a review. Stroke, 1997,28(3): 652.
-
7Sarti C, Pantoni L, Bartolini L, Inzitari D. Cognitive impairment and chronic cerebral hypoperfusion: what can be learned from experimental models. Journal of the neurological sciences, 2002, 203～204( 3 ): 263.
-
8Naassila M, Daoust M. Effect of prenatal and postnatal ethanol exposure on the developmental profile of mRNAs encoding NMDA receptor subunits in rat hippocampus Journal of Neurochemistry, 2002, 80(5): 850.
-
9Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curt Op Neurobiol, 2001, 11(3): 327.
-
10周艳,章军建,张晓琴.慢性脑缺血的实验研究进展[J].国外医学（脑血管疾病分册）,2002,10(5):386-388. 被引量：2
-
1王成伟.癌症治疗新策略——抗血管生成疗法[J].抗癌,2001(1):37-37.
-
2李敏,钱晓萍,刘宝瑞.肿瘤抗血管生成治疗临床应用进展[J].江苏医药,2007,33(2):194-195.
-
3肝细胞癌的缺氧状态[J].传染病网络动态,2008(1):19-19.
-
4王宋平,钱桂生.肿瘤血管生成及其抗血管生成治疗的研究进展[J].国际呼吸杂志,2007,27(21):1676-1680. 被引量：3
-
5王瑞婷,申兴斌,等.肿瘤的抗血管生成疗法[J].中国药理通讯,2003,20(1):68-68.
-
6王小华,张平.血管生成抑制剂TNP-470抗肿瘤研究和应用进展[J].南华大学学报（医学版）,2004,32(2):233-235.
-
7张则伟,赵彩芳.胰腺癌的抗血管生成治疗研究进展[J].浙江医学,2008,30(1):94-97. 被引量：2
-
8李正才,李晓江,马静,隋军.头颈部鳞状细胞癌抗血管生成治疗进展[J].国际耳鼻咽喉头颈外科杂志,2011,35(1):35-37.
-
9张继红.神经母细胞瘤的血管生成与抗血管治疗研究进展[J].国外医学（儿科学分册）,2001,28(6):296-299.
-
10白凤琴,程国华.血管内皮生长因子及其受体在上皮性卵巢癌中的表达及临床意义[J].临床医药实践,2007,16(10):985-987. 被引量：2
